TerminatedNot Applicable

Exploring The Role Of Palliative Care In Phase 1 Enrolled Pediatric Oncology Patients

Stopped: IRB approval to Close to accrual on 2-18-2025: Thematic saturation reached and enrolling further participants was deemed not necessary.

United States31 participantsStarted 2022-09-01

Plain-language summary

This study is being conducted to learn more about the patient/family experience when opting to enroll in Phase I clinical trials and their quality of life (QOL) while receiving experimental therapy. Palliative care (PC) has the potential to be beneficial for these families and further studies are needed to determine the most effective way for integration of PC into the care of patients enrolled on experimental clinical trials. Primary Objective * To qualitatively assess the patient and family experience, their hopes and worries and associated distress while deciding to enroll on a Phase I clinical trial.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Caregiver is 18 years of age or older * Caregiver is related to the patient in one of the following ways: biological parent, stepparent, or primary legal guardian * If more than 1 set of parents are involved in the patient's care (e.g., 2 biologic and 2 stepparents or partners) involved, the caregiver with legal decision- making responsibilities will be eligible for participation * Caregiver is comfortable speaking and reading English Exclusion Criteria: * Those who do not meet inclusion criteria

What they're measuring

Qualitative assessment of patient and family experience

Timeframe: Up to approximately 8 months after enrollment

Trial details

NCT IDNCT05412563

SponsorSt. Jude Children's Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-18

View on ClinicalTrials.gov More Quality of Life trials